Statin Therapy in Rheumatoid ArthritisA Cost-Effectiveness and Value-of-Information Analysis

被引：0
|
作者：
Nick Bansback
Roberta Ara
Sue Ward
Aslam Anis
Hyon K. Choi
机构：
[1] St Paul’s Hospital,Centre for Health Evaluation and Outcome Sciences
[2] University of Sheffield,School of Health and Related Research, Health Economics and Decision Sciences
[3] University of British Columbia,Department of Healthcare and Epidemiology
[4] University of British Columbia,Rheumatology Division, Department of Medicine, Arthritis Research Centre of Canada, Vancouver General Hospital
来源：
PharmacoEconomics | 2009年 / 27卷
关键词：
Rheumatoid Arthritis; Statin; Rheumatoid Arthritis Patient; Atorvastatin; Statin Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: HMG-CoA reductase inhibitors (statins) are potentially excellent candidate agents for patients with rheumatoid arthritis (RA). They reduce both cardiovascular risks and RA disease activity.
引用
收藏
页码：25 / 37
页数：12
相关论文
共 50 条
  • [21] Cost-effectiveness of Prescribing Antidepressants by Baseline Severity and Value of Information Analysis
    Thom, Howard
    Welton, Nicicy
    Kendrick, Tony
    Lewis, Glyn
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2015, 18 : S38 - S38
  • [22] Value engineering and cost-effectiveness analysis
    Gozhu, Han
    Xi Tong Gong Cheng Yu Dian Zi Ji Shu/Systems Engineering & Electronics, 1994, 16 (10):
  • [23] Using the Coronary Artery Calcium Score to Guide Statin Therapy A Cost-Effectiveness Analysis
    Pletcher, Mark J.
    Pignone, Michael
    Earnshaw, Stephanie
    McDade, Cheryl
    Phillips, Kathryn A.
    Auer, Reto
    Zablotska, Lydia
    Greenland, Philip
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (02): : 276 - 284
  • [24] Triple Therapy Versus Biologic Therapy for Active Rheumatoid Arthritis A Cost-Effectiveness Analysis
    Bansback, Nick
    Phibbs, Ciaran S.
    Sun, Huiying
    O'Dell, James R.
    Brophy, Mary
    Keystone, Edward C.
    Leatherman, Sarah
    Mikuls, Ted R.
    Anis, Aslam H.
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (01) : 8 - +
  • [25] Cost-effectiveness of Statin Use Guidelines
    Blum, Conrad B.
    Stone, Neil J.
    JAMA CARDIOLOGY, 2021, 6 (03) : 363 - 364
  • [26] Cost-effectiveness of rituximab therapy for rheumatoid arthritis: A Pan-European analysis
    Kielhorn, A
    Rubbert, A
    Porter, D
    De Vita, S
    Brown, B
    Aristides, M
    Aultman, R
    Jost, F
    VALUE IN HEALTH, 2006, 9 (03) : A27 - A27
  • [27] COST-EFFECTIVENESS ANALYSIS OF THE THERAPY OF ENDOMETRIOSIS
    Tuletova, A.
    Dochshanova, A.
    Skakova, R.
    VALUE IN HEALTH, 2014, 17 (07) : A511 - A511
  • [28] Cost-effectiveness of MS disease modifying agents: A Markov and value of information analysis
    Lundy, J
    Coons, SJ
    VALUE IN HEALTH, 2006, 9 (03) : A82 - A82
  • [29] Improving value measurement in cost-effectiveness analysis
    Ubel, PA
    Nord, E
    Gold, M
    Menzel, P
    Prades, JLP
    Richardson, J
    MEDICAL CARE, 2000, 38 (09) : 892 - 901
  • [30] COST-EFFECTIVENESS ANALYSIS OF GOLIMUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Desai, R. J.
    Rao, J.
    Biddle, A. K.
    VALUE IN HEALTH, 2012, 15 (04) : A39 - A39
12345